Abstract
The ability to adapt to stress is an important defensive function of a living body, and impairment of this ability may contribute to some stress-related disorders. Thus, the examination of brain mechanisms involved in stress adaptation could help to pave the way for new therapeutic strategies for stress-related affective disorders, such as anxiety and depression. The present review focuses on the roles of brain serotonin (5-hydroxytryptamine; 5-HT) neuronal systems, and especially 5-HT1A receptors, on the development of stress adaptation. Although animals exposed to acute stress stimuli exhibit various stress responses, these disappear after chronic exposure to the same type of stress stimuli, indicating the development of stress adaptation. The evidence obtained from studies using stress-adapted animals suggests that maintenance of the 5- HT neuronal response to stress stimuli together with down-regulation of 5-HT1A autoreceptors, as well as up-regulation of postsynaptic 5-HT1A receptors, may contribute to the formation of stress adaptation. In contrast, disappearance of the 5- HT neuronal response to stress stimuli and dysfunction of postsynaptic 5-HT1A receptors are observed in animals subjected to inadaptable stress stimuli. Furthermore, exogenous activation of 5-HT1A receptors by injection of 5-HT1A receptor agonists facilitates the ability to adapt to stressful situations, confirming that 5-HT1A receptors play an important role in the formation of stress adaptation. These findings suggest that the brain 5-HT neuronal system, and particularly 5- HT1A receptors, may play a key role in the development of stress adaptation, and maintenance of this system may be particularly important for preventing and / or treating affective disorders.
Keywords: 5-ht1a receptors, mediators, stress adaptation, stress-related affective disorders, anxiety, depression
Current Neuropharmacology
Title: Brain 5-HT1A Receptors as Important Mediators in the Development of Stress Adaptation
Volume: 1 Issue: 4
Author(s): Minoru Tsuji, Hiroshi Takeda and Teruhiko Matsumiya
Affiliation:
Keywords: 5-ht1a receptors, mediators, stress adaptation, stress-related affective disorders, anxiety, depression
Abstract: The ability to adapt to stress is an important defensive function of a living body, and impairment of this ability may contribute to some stress-related disorders. Thus, the examination of brain mechanisms involved in stress adaptation could help to pave the way for new therapeutic strategies for stress-related affective disorders, such as anxiety and depression. The present review focuses on the roles of brain serotonin (5-hydroxytryptamine; 5-HT) neuronal systems, and especially 5-HT1A receptors, on the development of stress adaptation. Although animals exposed to acute stress stimuli exhibit various stress responses, these disappear after chronic exposure to the same type of stress stimuli, indicating the development of stress adaptation. The evidence obtained from studies using stress-adapted animals suggests that maintenance of the 5- HT neuronal response to stress stimuli together with down-regulation of 5-HT1A autoreceptors, as well as up-regulation of postsynaptic 5-HT1A receptors, may contribute to the formation of stress adaptation. In contrast, disappearance of the 5- HT neuronal response to stress stimuli and dysfunction of postsynaptic 5-HT1A receptors are observed in animals subjected to inadaptable stress stimuli. Furthermore, exogenous activation of 5-HT1A receptors by injection of 5-HT1A receptor agonists facilitates the ability to adapt to stressful situations, confirming that 5-HT1A receptors play an important role in the formation of stress adaptation. These findings suggest that the brain 5-HT neuronal system, and particularly 5- HT1A receptors, may play a key role in the development of stress adaptation, and maintenance of this system may be particularly important for preventing and / or treating affective disorders.
Export Options
About this article
Cite this article as:
Tsuji Minoru, Takeda Hiroshi and Matsumiya Teruhiko, Brain 5-HT1A Receptors as Important Mediators in the Development of Stress Adaptation, Current Neuropharmacology 2003; 1 (4) . https://dx.doi.org/10.2174/1570159033477044
DOI https://dx.doi.org/10.2174/1570159033477044 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Initiation of Dialysis: A Mini-Review of a Changing Paradigm
Cardiovascular & Hematological Disorders-Drug Targets C-3 Functionalization of Indole Derivatives with Isoquinolines
Current Organic Chemistry Endoplasmic Reticulum Dysfunction in Brain Pathology: Critical Role of Protein Synthesis
Current Neurovascular Research The Urocortins: Mechanisms of Cardioprotection and Therapeutic Potential
Mini-Reviews in Medicinal Chemistry Topics on Pharmacology for Dietitians in Modern Practice
Current Nutrition & Food Science The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis
Current Neuropharmacology Recent Advances in Protein and Peptide Drug Delivery: A Special Emphasis on Polymeric Nanoparticles
Protein & Peptide Letters Editorial: Current Strategies in Targeting Brain Disorders
CNS & Neurological Disorders - Drug Targets Pro-Inflammatory Gene Variants in Myocardial Infarction and Longevity: Implications for Pharmacogenomics
Current Pharmaceutical Design Inflammatory Mediators in Smoke Inhalation Injury
Inflammation & Allergy - Drug Targets (Discontinued) Fruit as Potent Natural Antioxidants and Their Biological Effects
Current Pharmaceutical Biotechnology Meningococcal Disease and Future Drug Targets
CNS & Neurological Disorders - Drug Targets The Phosphoinositide 3-Kinase Pathway in Human Cancer: Genetic Alterations and Therapeutic Implications
Current Genomics The Emerging Role of the Double-Edged Impact of Arachidonic Acid- Derived Eicosanoids in the Neuroinflammatory Background of Depression.
Current Neuropharmacology Receptor-Based Design of Cytokine Therapeutics
Current Pharmaceutical Biotechnology Targeting the Hedgehog Pathway: The development of Cyclopamine and the Development of Anti-Cancer Drugs Targeting the Hedgehog Pathway
Mini-Reviews in Medicinal Chemistry Momordica balsamina: A Medicinal and Neutraceutical Plant for Health Care Management
Current Pharmaceutical Biotechnology Phosphoinositide-3-kinases as the Novel Therapeutic Targets for the Inflammatory Diseases: Current and Future Perspectives
Current Drug Targets Oxidative Stress, Mitochondrial Abnormalities and Proteins Deposition: Multitarget Approaches in Alzheimer's Disease
Current Topics in Medicinal Chemistry Cell and Gene Therapies for Refractory Epilepsy
Current Neuropharmacology